RBL Communications
  • Home
  • About
  • Services
  • Investment Hub
  • Contact
Select Page

Anfield Energy Receives Affirmative Completeness Review of its Shootaring Mill Restart Application from the State of Utah

Jul 18, 2024

VANCOUVER, British Columbia, July 18, 2024 – Anfield Energy, Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has received an affirmative completeness review from the State of Utah’s Department of...

Boba Mint Launches Tanjea Token to the Ethereum Layer 2 Blockchain Arbitrum

Jun 24, 2024

Vancouver, British Columbia – June 24, 2024 – Boba Mint Holdings Ltd. (CSE: TNJ) (“Boba” or the “Company”) is pleased to announce that the gaming community celebrates today as Tanjea Token, a new digital token, makes its debut on the Ethereum layer 2 blockchain,...

Anfield Receives Drill Program Permit Application Approval for Slick Rock

Jun 17, 2024

VANCOUVER, British Columbia, June 17, 2024 – Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that it has received final approvals for its drill permit application to commence a 20-hole,...

Boba Mint Announces CEO Transition: Michael Zon to Assume Technical Advisor Role, Rody Lazar Appointed as New CEO

Jun 14, 2024

June 14, 2024 – Vancouver, British Columbia – Boba Mint Holdings Ltd. (CSE: TNJ) (“Boba” or the “Company, today announced a significant leadership transition. Michael Zon, who has served as the company’s CEO since inception, will be stepping down from his...

Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID

Jun 12, 2024

TORONTO, June 12, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical...

Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product

Jun 10, 2024

TORONTO, June 10, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical...
« Older Entries
Next Entries »

Follow Us

Categories

  • Al O'Grady
  • Anfield Energy
  • Blog
  • Boba Mint Holdings
  • Kontrol Energy
  • News
  • PharmaDrug
  • Revive
  • Uncategorized
  • Home
  • About
  • Services
  • Investment Hub
  • Contact
  • Facebook
  • X
© COPYRIGHT 2025. RBL Communications Inc. ALL RIGHTS RESERVED.